Ocular Therapeutix (OCUL) CSO Jeffrey S. Heier Sells Shares

What Happened

• Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix (OCUL), disposed of 3,296 shares on August 24, 2026 in an open-market sale. The weighted-average sale price was $10.78 per share, for total proceeds of approximately $35,531. The sale was to satisfy tax withholding on restricted stock units and was executed under a pre-existing automatic instruction—not a discretionary trade.

Key Details

• Transaction date: 2026-08-24; Form filed: 2026-08-26 (appears timely).
• Transaction type: Sale (S) executed as tax withholding/sell-to-cover per durable instruction.
• Price: Weighted average $10.78; individual sale prices ranged $10.6425–$10.9125 (multiple trades). Reporting person will provide breakdown on request per filing.
• Purpose/footnote: F1—sell-to-cover election adopted Apr 9, 2024 to satisfy tax withholding on RSU vesting (vested Aug 22, 2026). F2—weighted avg and price range disclosure. F3—notation that 1,272 shares were acquired via the company's ESPP on June 30, 2026.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.

Context

• This was a routine tax-withholding sale tied to RSU vesting and was executed under pre-set instructions, which typically does not signal a discretionary sell decision by the insider. Purchases generally carry more informational weight for investors; this filing documents a tax-related disposition.